RHYTHM PHARMACEUTICALS, INC. (RYTM) Operating income 2016–2025
RHYTHM PHARMACEUTICALS, INC. (RYTM) annual operating income history from SEC filings — each fiscal year as reported.
-$192.0MFY2025 · since FY2016: -$25.9M → -$192.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$192.0M | +27.7% |
| FY2024 | -$265.5M | -44.0% |
| FY2023 | -$184.4M | -2.9% |
| FY2022 | -$179.2M | -5.3% |
| FY2021 | -$170.1M | -24.5% |
| FY2020 | -$136.6M | +6.5% |
| FY2019 | -$146.0M | -86.2% |
| FY2018 | -$78.4M | -141.9% |
| FY2017 | -$32.4M | -25.1% |
| FY2016 | -$25.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice